AbbVie Inc. - FORM 10-K - EX-12 - February 19, 2016

Attached files

file filename
EX-21 - EX-21 - AbbVie Inc.a2227341zex-21.htm
EX-23 - EX-23 - AbbVie Inc.a2227341zex-23.htm
EX-31.1 - EX-31.1 - AbbVie Inc.a2227341zex-31_1.htm
EX-10.4 - EX-10.4 - AbbVie Inc.a2227341zex-10_4.htm
EX-10.6 - EX-10.6 - AbbVie Inc.a2227341zex-10_6.htm
EX-32.2 - EX-32.2 - AbbVie Inc.a2227341zex-32_2.htm
EX-31.2 - EX-31.2 - AbbVie Inc.a2227341zex-31_2.htm
EX-10.5 - EX-10.5 - AbbVie Inc.a2227341zex-10_5.htm
EX-32.1 - EX-32.1 - AbbVie Inc.a2227341zex-32_1.htm
EX-10.8 - EX-10.8 - AbbVie Inc.a2227341zex-10_8.htm
10-K - 10-K - AbbVie Inc.a2227341z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 12

RATIO OF EARNINGS TO FIXED CHARGES

        The following table sets forth AbbVie's historical ratios of earnings to fixed charges for the periods indicated. This information should be read in conjunction with the financial statements and accompanying notes included under Item 8, "Financial Statements and Supplementary Data" and Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations."

 
   Year Ended December 31,  
 
   2015
   2014
   2013
   2012
   2011
  
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Ratio of Earnings to Fixed Charges

     8.0     6.0     16.6     41.3     132.0  
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

 



QuickLinks

RATIO OF EARNINGS TO FIXED CHARGES

Stock widget

Investing forum

AbbVie Inc. Reports